Pub Date : 2019-09-30DOI: 10.24292/01.ot.300919.02
Dorota Pożarowska, T. Żarnowski
Malignant glaucoma is a rare but serious complication of intraocular surgery. Most frequently it occurs after penetrating antiglaucoma procedures
恶性青光眼是眼内手术中一种罕见但严重的并发症。它最常发生在穿透性抗青光眼手术后
{"title":"Jaskra złośliwa: nowe poglądy na etiopatogenezę i postępowanie","authors":"Dorota Pożarowska, T. Żarnowski","doi":"10.24292/01.ot.300919.02","DOIUrl":"https://doi.org/10.24292/01.ot.300919.02","url":null,"abstract":"Malignant glaucoma is a rare but serious complication of intraocular surgery. Most frequently it occurs after penetrating antiglaucoma procedures","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133353993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-30DOI: 10.24292/01.ot.300919.03
M. Misiuk-Hojło, Katarzyna Zimmer
{"title":"Glaucoma and cataract: the effect of the phacoemulsification procedures and the combined procedures on the intraocular pressure","authors":"M. Misiuk-Hojło, Katarzyna Zimmer","doi":"10.24292/01.ot.300919.03","DOIUrl":"https://doi.org/10.24292/01.ot.300919.03","url":null,"abstract":"","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132890044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-06-30DOI: 10.24292/01.OT.300619.08
P. Klonowski, A. Prokopiuk
Purpose: To evaluate distance, near and intermediate visual acuity, objective refraction, corneal keratometry and rotational stability after cataract surgery with an implantation of multifocal toric AcrySof® IQ PanOptix TFNTx intraocular lens in one-year follow-up. Material and methods: A total of 20 eyes of 14 patients underwent 2.2 mm coaxial cataract surgery with an implantation of AcrySof® IQ PanOptix TFNTx intraocular lens. Before surgery uncorrected and best-corrected distance visual acuity, objective refraction and corneal keratometry were evaluated. Twelve months after the surgery uncorrected and best-corrected distance visual acuity, uncorrected near and intermediate visual acuity, objective refraction, corneal keratometry and rotational stability of the implant were analyzed. Results: One year after the surgery there was statistically significant improve-ment of uncorrected and best-corrected distance visual acuity (p = 0.005 and p = 0.016). There was no significant change in corneal keratometry in flat and steep meridian (p = 0.94 and p = 0.63) and keratometric cylinder (p = 0.49). There was statistically significant decrease in objective refraction cylinder (p = 0.002). The mean rotation of an implanted intraocular lens axis was 2.51°. There were no intra- and post-operative complications in any of the patients. Conclusions: AcrySof® IQ PanOptix TFNTx intraocular lens implantation is a safe and effective method to correct presbyopia coexisting with corneal astigmatism during cataract surgery.
{"title":"Application of intraocular multifocal toric lenses in the correction of presbyopia and corneal astigmatism in cataract surgery – analysis of the refraction outcome and axial stability of the AcrySof® IQ PanOptix TFNTx Intraocular Lens","authors":"P. Klonowski, A. Prokopiuk","doi":"10.24292/01.OT.300619.08","DOIUrl":"https://doi.org/10.24292/01.OT.300619.08","url":null,"abstract":"Purpose: To evaluate distance, near and intermediate visual acuity, objective refraction, corneal keratometry and rotational stability after cataract surgery with an implantation of multifocal toric AcrySof® IQ PanOptix TFNTx intraocular lens in one-year follow-up. Material and methods: A total of 20 eyes of 14 patients underwent 2.2 mm coaxial cataract surgery with an implantation of AcrySof® IQ PanOptix TFNTx intraocular lens. Before surgery uncorrected and best-corrected distance visual acuity, objective refraction and corneal keratometry were evaluated. Twelve months after the surgery uncorrected and best-corrected distance visual acuity, uncorrected near and intermediate visual acuity, objective refraction, corneal keratometry and rotational stability of the implant were analyzed. Results: One year after the surgery there was statistically significant improve-ment of uncorrected and best-corrected distance visual acuity (p = 0.005 and p = 0.016). There was no significant change in corneal keratometry in flat and steep meridian (p = 0.94 and p = 0.63) and keratometric cylinder (p = 0.49). There was statistically significant decrease in objective refraction cylinder (p = 0.002). The mean rotation of an implanted intraocular lens axis was 2.51°. There were no intra- and post-operative complications in any of the patients. Conclusions: AcrySof® IQ PanOptix TFNTx intraocular lens implantation is a safe and effective method to correct presbyopia coexisting with corneal astigmatism during cataract surgery.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"183 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125830178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-06-30DOI: 10.24292/01.OT.300619.09
Tomasz Kuc, Rafał Pawlikowski, Martyna Zuterek, Monika Gołębiowska, Piotr Pyrzanowski
The paper presents the original technique of transcleral fixation toric IOL with the assist of the VerionTM system in patients in which intracapsular implantation cannot be performed. This technique enables to predict the location of the fixation and the lens setting in the correct axis for astigmatism. In the paper we defined the term of angle of lens fixation, the means of its measurement as well as modification of VerionTM system setting. It enabled us to designate target location of lens fixation. The technique improved the refraction of the patient, by which the implant could not be done by classical method.
{"title":"Posterior vitrectomy with transscleral fixation of the toric lens and the assistance of the Verion™ system – case report","authors":"Tomasz Kuc, Rafał Pawlikowski, Martyna Zuterek, Monika Gołębiowska, Piotr Pyrzanowski","doi":"10.24292/01.OT.300619.09","DOIUrl":"https://doi.org/10.24292/01.OT.300619.09","url":null,"abstract":"The paper presents the original technique of transcleral fixation toric IOL with the assist of the VerionTM system in patients in which intracapsular implantation cannot be performed. This technique enables to predict the location of the fixation and the lens setting in the correct axis for astigmatism. In the paper we defined the term of angle of lens fixation, the means of its measurement as well as modification of VerionTM system setting. It enabled us to designate target location of lens fixation. The technique improved the refraction of the patient, by which the implant could not be done by classical method.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131454389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-06-30DOI: 10.24292/01.OT.300619.01
J. Czajkowski, R. Grabowski
{"title":"The influence of ultraviolet radiation on the eyes and periocular skin","authors":"J. Czajkowski, R. Grabowski","doi":"10.24292/01.OT.300619.01","DOIUrl":"https://doi.org/10.24292/01.OT.300619.01","url":null,"abstract":"","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129099956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-06-30DOI: 10.24292/01.OT.300619.06
A. Bryl, M. Mrugacz
{"title":"Ranibizumab in the treatment of diabetic macular edema","authors":"A. Bryl, M. Mrugacz","doi":"10.24292/01.OT.300619.06","DOIUrl":"https://doi.org/10.24292/01.OT.300619.06","url":null,"abstract":"","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"160 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121328638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-06-30DOI: 10.24292/01.OT.300619.04
Izabela K Garaszczuk
{"title":"The recommended diagnostic protocol for dry eye disease","authors":"Izabela K Garaszczuk","doi":"10.24292/01.OT.300619.04","DOIUrl":"https://doi.org/10.24292/01.OT.300619.04","url":null,"abstract":"","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"110 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123935393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-06-30DOI: 10.24292/01.OT.300619.05
Dorota H. Szczesna-Iskander, M. Muzyka-Woźniak, M. Osęka
streszczeNie Cel: Ocena skuteczności 3 powszechnie stosowanych preparatów sztucznych łez u pacjentów z objawami zespołu suchego oka. Materiał i metody: W 4-tygodniowym badaniu uczestniczyło 30 osób z objawami suchego oka. Badani w schemacie 1 : 1 : 1 otrzymywali: grupa 1. – dekspantenol 2% i hydroksypropylocelulozę 0,5%; grupa 2. – trehalozę 3% i hialuronian sodu 0,15%; grupa 3. – hialuronian sodu 0,24%. Badania wykonano przed rozpoczęciem leczenia i po 28 dniach. Zastosowano kwestionariusz OSDI wskaźnika choroby powierzchni oka, ocenę objawów subiektywnych, nieinwazyjne obrazowe badania diagnostyczne 2 wideokeratoskopami z dużą i małą czaszą projekcyjną, test Schirmera oraz badania w lampie szczelinowej z barwieniem fluoresceiną i zielenią lizaminy. W analizie statystycznej użyto testu t-Studenta dla prób zależnych. Wyniki: Wszystkie preparaty doprowadziły do poprawy OSDI. W grupie 1. redukcji uległy cztery, a w grupach 2. i 3. – dwa subiektywne objawy suchego oka (p < 0,05). Nieinwazyjny czas przerwania filmu łzowego (NIBUT) był znacząco dłuższy w grupach 1. i 3. (p < 0,05) jedynie w pomiarach wideokeratoskopem z małą czaszą. Tempo postępującego pogarszania się jakości powierzchni filmu łzowego po mrugnięciu uległo spowolnieniu tylko w grupie 1. (p < 0,05). Stopień barwienia rogówki fluoresceiną zmniejszył się we wszystkich grupach (p < 0,05). Nie zaobserwowano istotnych zmian w teście Schirmera, wysokości menisku łzowego i w NIBUT mierzonym wideokeratoskopem z dużą czaszą. Wnioski: Badane preparaty zmniejszyły subiektywne i obiektywne objawy zespołu suchego oka. Znacząco polepszyły komfort pacjenta i stan nabłonka rogówki. Poprawa stabilności filmu łzowego zależała od rodzaju kropli i metody badawczej.
{"title":"The use of non-invasive and invasive diagnostic methods to evaluate the effectiveness of three artificial tear preparations in the treatment of dry eye syndrome","authors":"Dorota H. Szczesna-Iskander, M. Muzyka-Woźniak, M. Osęka","doi":"10.24292/01.OT.300619.05","DOIUrl":"https://doi.org/10.24292/01.OT.300619.05","url":null,"abstract":"streszczeNie Cel: Ocena skuteczności 3 powszechnie stosowanych preparatów sztucznych łez u pacjentów z objawami zespołu suchego oka. Materiał i metody: W 4-tygodniowym badaniu uczestniczyło 30 osób z objawami suchego oka. Badani w schemacie 1 : 1 : 1 otrzymywali: grupa 1. – dekspantenol 2% i hydroksypropylocelulozę 0,5%; grupa 2. – trehalozę 3% i hialuronian sodu 0,15%; grupa 3. – hialuronian sodu 0,24%. Badania wykonano przed rozpoczęciem leczenia i po 28 dniach. Zastosowano kwestionariusz OSDI wskaźnika choroby powierzchni oka, ocenę objawów subiektywnych, nieinwazyjne obrazowe badania diagnostyczne 2 wideokeratoskopami z dużą i małą czaszą projekcyjną, test Schirmera oraz badania w lampie szczelinowej z barwieniem fluoresceiną i zielenią lizaminy. W analizie statystycznej użyto testu t-Studenta dla prób zależnych. Wyniki: Wszystkie preparaty doprowadziły do poprawy OSDI. W grupie 1. redukcji uległy cztery, a w grupach 2. i 3. – dwa subiektywne objawy suchego oka (p < 0,05). Nieinwazyjny czas przerwania filmu łzowego (NIBUT) był znacząco dłuższy w grupach 1. i 3. (p < 0,05) jedynie w pomiarach wideokeratoskopem z małą czaszą. Tempo postępującego pogarszania się jakości powierzchni filmu łzowego po mrugnięciu uległo spowolnieniu tylko w grupie 1. (p < 0,05). Stopień barwienia rogówki fluoresceiną zmniejszył się we wszystkich grupach (p < 0,05). Nie zaobserwowano istotnych zmian w teście Schirmera, wysokości menisku łzowego i w NIBUT mierzonym wideokeratoskopem z dużą czaszą. Wnioski: Badane preparaty zmniejszyły subiektywne i obiektywne objawy zespołu suchego oka. Znacząco polepszyły komfort pacjenta i stan nabłonka rogówki. Poprawa stabilności filmu łzowego zależała od rodzaju kropli i metody badawczej.","PeriodicalId":112284,"journal":{"name":"OphthaTherapy. Therapies in Ophthalmology","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123978849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：